Prevention and/or treatment of neurodegenerative disease

    公开(公告)号:GB2568986A

    公开(公告)日:2019-06-05

    申请号:GB201807590

    申请日:2018-05-10

    Abstract: A composition comprising at least one carotenoid selected from the group consisting of lutein, zeaxanthin and meso-zeaxanthin; and a composition comprising at least one omega-3 fatty acid; for use in the prevention and/or treatment of dementia in a human subject is provided. The omega-3 fatty acid is preferably docosahexaenoic acid (DHA). A further omega-3 fatty acid, preferably eicosapentaenoic acid (EPA) may be present. The omega-3 fatty acid is preferably provided as a component of fish oil. The composition comprising at least one carotenoid may contain each of lutein, zeaxanthin and meso-zeaxanthin. The compositions may be formulated for oral consumption, preferably in the form of a capsule or tablet. The form of dementia is preferably Alzheimer’s disease.

    Prevention and/or treatment of neurodegenerative disease

    公开(公告)号:GB201720119D0

    公开(公告)日:2018-01-17

    申请号:GB201720119

    申请日:2017-12-04

    Abstract: A method for the prevention and/or treatment of dementia in a human subject; the method comprising the step of administering an effective amount of a composition comprising at least one carotenoid selected from the group consisting of lutein, zeaxanthin and meso-zeaxanthin; and a composition comprising at least one omega-3 fatty acid.

Patent Agency Ranking